APA

Nicklas A. P., Kramer M. W., Serth J., Hennenlotter J., Hupe M. C., Reimer D. U., Stenzl A., Merseburger A. S., Kuczyk M. A. & von Klot C. J. (20190926). Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). : Advances in therapy.

Chicago

Nicklas André P, Kramer Mario W, Serth Jürgen, Hennenlotter Jörg, Hupe Marie C, Reimer Daniel U, Stenzl Arnulf, Merseburger Axel S, Kuczyk Markus A and von Klot Christoph-Alexander J. 20190926. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). : Advances in therapy.

Harvard

Nicklas A. P., Kramer M. W., Serth J., Hennenlotter J., Hupe M. C., Reimer D. U., Stenzl A., Merseburger A. S., Kuczyk M. A. and von Klot C. J. (20190926). Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). : Advances in therapy.

MLA

Nicklas André P, Kramer Mario W, Serth Jürgen, Hennenlotter Jörg, Hupe Marie C, Reimer Daniel U, Stenzl Arnulf, Merseburger Axel S, Kuczyk Markus A and von Klot Christoph-Alexander J. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). : Advances in therapy. 20190926.